Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 595

2.

Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness.

Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.

Neuro Endocrinol Lett. 2009;30(4):462-9.

PMID:
20010493
4.

Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.

Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.

Neuro Endocrinol Lett. 2009;30(6):715-22.

PMID:
20035260
6.

An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways.

Maes M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):784-94. doi: 10.1016/j.pnpbp.2010.06.023. Epub 2010 Jul 4. Review.

PMID:
20609377
7.
10.
12.

Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome.

Maes M, Mihaylova I, Kubera M, Bosmans E.

Neuro Endocrinol Lett. 2007 Aug;28(4):463-9.

PMID:
17693978
13.

Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Morris G, Maes M.

Med Hypotheses. 2012 Nov;79(5):607-13. doi: 10.1016/j.mehy.2012.07.034. Epub 2012 Aug 27.

PMID:
22951418
14.

In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.

Maes M, Ringel K, Kubera M, Anderson G, Morris G, Galecki P, Geffard M.

J Affect Disord. 2013 Sep 5;150(2):223-30. doi: 10.1016/j.jad.2013.03.029. Epub 2013 May 10.

PMID:
23664637
15.

Chronic fatigue syndrome: la bête noire of the Belgian health care system.

Maes M, Twisk FN.

Neuro Endocrinol Lett. 2009;30(3):300-11. Review.

PMID:
19855351
16.

Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome.

Hoad A, Spickett G, Elliott J, Newton J.

QJM. 2008 Dec;101(12):961-5. doi: 10.1093/qjmed/hcn123. Epub 2008 Sep 19.

PMID:
18805903
17.

Abnormalities in pH handling by peripheral muscle and potential regulation by the autonomic nervous system in chronic fatigue syndrome.

Jones DE, Hollingsworth KG, Taylor R, Blamire AM, Newton JL.

J Intern Med. 2010 Apr;267(4):394-401. doi: 10.1111/j.1365-2796.2009.02160.x.

20.

Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.

Maes M.

Mod Trends Pharmacopsychiatry. 2013;28:162-74. doi: 10.1159/000343982. Epub 2013 Feb 27. Review.

PMID:
25224898

Supplemental Content

Support Center